Suppr超能文献

基于机制的阿尔茨海默病治疗方法。

Mechanism-based treatments for Alzheimer's disease.

作者信息

Davies Peter, Koppel Jeremy

机构信息

Litwin-Zucker Center for Research on Alzheimer's Disease, Feinstein Institute for Medical Research, Manhasset, NY 11030, USA.

出版信息

Dialogues Clin Neurosci. 2009;11(2):159-69. doi: 10.31887/DCNS.2009.11.2/pdavies.

Abstract

Treatment for Alzheimer's disease is entering a new and exciting phase, with several new drugs beginning clinical trials. Many of these new therapies are based on our best current understanding of the pathogenesis of Alzheimer's disease, and are designed to try to either slow or halt the progression of the disease. There are several different theories underlying the current efforts, and these are briefly reviewed. Therapies directed against some aspect of beta-amyloid formation, against neurofibrillary tangle formation and against the inflammatory response are all considered, as are the problems associated with each area. It is as yet unclear which, if any, of these approaches will be successful, but the high level of activity in each of these three fields provides some hope that an effective treatment for Alzheimer's disease is on the horizon.

摘要

阿尔茨海默病的治疗正进入一个全新且令人振奋的阶段,有几种新药已开始临床试验。这些新疗法中的许多都是基于我们目前对阿尔茨海默病发病机制的最佳理解而设计的,旨在减缓或阻止疾病的进展。当前的研究工作有几种不同的理论基础,在此将简要回顾。针对β-淀粉样蛋白形成的某些方面、神经原纤维缠结形成以及炎症反应的疗法均在考虑范围内,同时也会探讨与每个领域相关的问题。目前尚不清楚这些方法中是否有任何一种会取得成功,但这三个领域各自的高度活跃态势让人们看到了希望,即有效的阿尔茨海默病治疗方法即将出现。

相似文献

1
Mechanism-based treatments for Alzheimer's disease.
Dialogues Clin Neurosci. 2009;11(2):159-69. doi: 10.31887/DCNS.2009.11.2/pdavies.
2
Treatments for Alzheimer's disease emerge.
Science. 2021 Aug 6;373(6555):624-626. doi: 10.1126/science.abi6401.
3
A new kind of Alzheimer's disease plaque.
Adv Anat Pathol. 1998 May;5(3):170-4. doi: 10.1097/00125480-199805000-00004.
4
Current therapeutic targets for the treatment of Alzheimer's disease.
Expert Rev Neurother. 2010 May;10(5):711-28. doi: 10.1586/ern.10.29.
5
Neurofibrillary tangles and beta-amyloid deposits in Alzheimer's disease.
Curr Opin Neurobiol. 1991 Oct;1(3):441-7. doi: 10.1016/0959-4388(91)90067-h.
6
Tarenflurbil: a shot on goal.
Lancet Neurol. 2008 Jun;7(6):468-9. doi: 10.1016/S1474-4422(08)70091-7. Epub 2008 Apr 29.
7
Alzheimer's disease: Mental plaque removal.
Nature. 2003 May 22;423(6938):392-3. doi: 10.1038/423392a.
8
[Therapy of Alzheimer disease].
Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33.
9
[Alzheimer's disease: cellular and molecular aspects].
Bull Acad Natl Med. 2008 Feb;192(2):323-31; discussion 331-2.

引用本文的文献

1
Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives.
IBRO Neurosci Rep. 2023 Nov 30;16:8-42. doi: 10.1016/j.ibneur.2023.11.003. eCollection 2024 Jun.
3
Amylin in Alzheimer's disease: Pathological peptide or potential treatment?
Neuropharmacology. 2018 Jul 1;136(Pt B):287-297. doi: 10.1016/j.neuropharm.2017.12.016. Epub 2017 Dec 9.
5
Half-life of DISC1 protein and its pathological significance under hypoxia stress.
Neurosci Res. 2015 Aug;97:1-6. doi: 10.1016/j.neures.2015.02.008. Epub 2015 Mar 1.
6
Role of grape seed polyphenols in Alzheimer's disease neuropathology.
Nutr Diet Suppl. 2010 Aug 1;2010(2):97-103. doi: 10.2147/NDS.S6898.
8
Tau in Alzheimer disease and related tauopathies.
Curr Alzheimer Res. 2010 Dec;7(8):656-64. doi: 10.2174/156720510793611592.

本文引用的文献

2
Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.
Neuron. 2008 Nov 26;60(4):534-42. doi: 10.1016/j.neuron.2008.11.007.
3
Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.
J Alzheimers Dis. 2008 Oct;15(2):157-68. doi: 10.3233/jad-2008-15202.
5
Is tau aggregation toxic or protective?
J Alzheimers Dis. 2008 Aug;14(4):453-7. doi: 10.3233/jad-2008-14415.
6
Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
J Neurosci. 2008 Jul 2;28(27):6787-93. doi: 10.1523/JNEUROSCI.2377-07.2008.
9
A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study.
Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):21-9. doi: 10.1097/WAD.0b013e3181611024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验